Burning Rock Biotech Ltd. (BNR)
11.68
+0.08
(+0.69%)
USD |
NASDAQ |
Sep 15, 16:00
13.29
+1.61
(+13.78%)
Pre-Market: 08:46
Burning Rock Biotech Enterprise Value : 47.50M for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 47.50M |
| September 14, 2026 | 46.80M |
| September 11, 2026 | 52.77M |
| September 10, 2026 | 46.97M |
| September 09, 2026 | 50.22M |
| September 08, 2026 | 38.98M |
| September 04, 2026 | 50.22M |
| September 03, 2026 | 39.59M |
| September 02, 2026 | 25.27M |
| September 01, 2026 | 25.89M |
| August 31, 2026 | 27.91M |
| August 28, 2026 | 34.41M |
| August 27, 2026 | 32.74M |
| August 26, 2026 | 36.61M |
| August 25, 2026 | 30.98M |
| August 24, 2026 | 35.55M |
| August 21, 2026 | 30.81M |
| August 20, 2026 | 26.15M |
| August 19, 2026 | 30.90M |
| August 18, 2026 | 26.68M |
| August 17, 2026 | 24.83M |
| August 14, 2026 | 22.46M |
| August 13, 2026 | 26.50M |
| August 12, 2026 | 32.13M |
| August 11, 2026 | 36.44M |
| Date | Value |
|---|---|
| August 10, 2026 | 40.27M |
| August 07, 2026 | 22.29M |
| August 06, 2026 | 22.90M |
| August 05, 2026 | 22.90M |
| August 04, 2026 | 23.69M |
| August 03, 2026 | 22.55M |
| July 31, 2026 | 23.08M |
| July 30, 2026 | 22.64M |
| July 29, 2026 | 22.37M |
| July 28, 2026 | 25.62M |
| July 27, 2026 | 27.47M |
| July 24, 2026 | 23.52M |
| July 23, 2026 | 23.52M |
| July 22, 2026 | 25.18M |
| July 21, 2026 | 27.91M |
| July 20, 2026 | 33.36M |
| July 17, 2026 | 32.48M |
| July 16, 2026 | 29.27M |
| July 15, 2026 | 26.59M |
| July 14, 2026 | 32.21M |
| July 13, 2026 | 38.54M |
| July 10, 2026 | 44.16M |
| July 09, 2026 | 47.68M |
| July 08, 2026 | 48.12M |
| July 07, 2026 | 39.29M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 466.23M |
| BioRestorative Therapies, Inc. | -0.1944M |
| CareDx, Inc. | 2.356B |
| Natera, Inc. | 49.52B |
| WuXi AppTec Co., Ltd. | 8.508B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.705M |
| Revenue (Quarterly) | 19.80M |
| Total Expenses (Quarterly) | 22.50M |
| EPS Diluted (Quarterly) | -0.249 |
| Gross Profit Margin (Quarterly) | 72.58% |
| Profit Margin (Quarterly) | -13.66% |
| Earnings Yield | -7.81% |
| Normalized Earnings Yield | -7.812 |